Bone mineral density among systemic lupus erythematosus patient age 5-18 years with glucocorticoid treatment in child and adolescent outpatient clinic, Cipto Mangunkusumo Hospital, Jakarta

1st Physics and Technologies in Medicine and Dentistry Symposium

物理学;医药卫生

Indriyani, N.^1 ; Tridjaja, B.^1 ; Medise, B.E.^1 ; Kurniati, N.^1

Department of Pediatric, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia^1

关键词: ALkaline phosphatase;    Autoimmune disease;    Body mass index;    Bone metabolism;    Bone mineral density;    Cross-sectional study;    Outpatient clinic;    Systemic lupus erythematosus;   

Others  :  https://iopscience.iop.org/article/10.1088/1742-6596/884/1/012078/pdf
DOI  :  10.1088/1742-6596/884/1/012078

学科分类：卫生学

来源: IOP

【 摘 要 】

Systemic lupus erythematosus (SLE) is an autoimmune disease affecting children; its morbidity and mortality rates are significant. One risk factor for morbidity is chronic corticosteroid use. The aim of this study is to determine the occurrence rate of low bone mineral density; discuss the characteristics, including cumulative and daily doses of corticosteroid, body mass index, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), calcium, and Vitamin D intake; and assess bone metabolism laboratory parameters, including serum calcium, Vitamin D, alkaline phosphatase (ALP), phosphorus, and cortisol among children with SLE receiving corticosteroids. This was a descriptive, cross-sectional study involving 16 children with SLE attending the child and adolescent outpatient clinic at Cipto Mangunkusumo Hospital in November-December 2016. Low bone mineral density occurred among 7/16 patients. The mean total bone mineral density was 0.885 ±0.09 g/cm2. Children with SLE receiving corticosteroid had low calcium (8.69 ±0.50 mg/dl), Vitamin D (19.3 ±5.4 mg/dl), ALP (79.50 [43.00-164.00] U/l), and morning cortisol level (1.20 [0.0-10.21] ug/dl), as well as calcium (587.58 ±213.29 mg/d) and Vitamin D (2.9 [0-31.8] mcg/d) intake. The occurrence of low bone mineral density was observed among children with SLE receiving corticosteroid treatment. Low bone mineral density tends to occur among patients with higher cumulative doses and longer duration of corticosteroid treatments.